Effect of Sodium-glucose Cotransporter-2 Inhibitor in Cellular Senescence in Patients With Cardiovascular Diseases or Type 2 Diabetes

Clinical trial NCT05975528 · UNKNOWN

Trial details

NCT number: NCT05975528
Sponsor: Yonsei University
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus Cellular Senescence Sodium-Glucose Transporter 2 Inhibitors

Start date: 2023-06-01
Primary completion: 2025-12-31
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.